920 related articles for article (PubMed ID: 10657470)
1. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
2. 4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity?
Knight YE; Edvinsson L; Goadsby PJ
Neuropharmacology; 2001 Mar; 40(4):520-5. PubMed ID: 11249961
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.
Goadsby PJ; Hoskin KL
Pain; 1999 Jul; 82(1):15-22. PubMed ID: 10422655
[TBL] [Abstract][Full Text] [Related]
4. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
Hoskin KL; Goadsby PJ
Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
6. The trigemino-vascular system and migraine.
Buzzi MG; Moskowitz MA
Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707
[TBL] [Abstract][Full Text] [Related]
7. Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
Knyihár-Csillik E; Tajti J; Chadaide Z; Csillik B; Vécsei L
Microsc Res Tech; 2001 May; 53(3):193-211. PubMed ID: 11301495
[TBL] [Abstract][Full Text] [Related]
8. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
Goadsby PJ; Edvinsson L
Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
[TBL] [Abstract][Full Text] [Related]
9. Neurogenic inflammation in the context of migraine.
Williamson DJ; Hargreaves RJ
Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
[TBL] [Abstract][Full Text] [Related]
10. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model.
Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L
J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668
[TBL] [Abstract][Full Text] [Related]
11. Effects of sumatriptan on capsaicin-induced carotid haemodynamic changes and CGRP release in anaesthetized pigs.
Arulmani U; Heiligers JP; Garrelds IM; Sánchez-López A; Willems EW; Villalón CM; Saxena PR
Cephalalgia; 2004 Sep; 24(9):717-27. PubMed ID: 15315527
[TBL] [Abstract][Full Text] [Related]
12. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
Goadsby PJ; Hoskin KL
Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
[TBL] [Abstract][Full Text] [Related]
13. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
14. Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs.
Lynch JJ; Shen YT; Pittman TJ; Anderson KD; Koblan KS; Gould RJ; Regan CP; Kane SA
Eur J Pharmacol; 2009 Nov; 623(1-3):96-102. PubMed ID: 19766109
[TBL] [Abstract][Full Text] [Related]
15. Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine.
Piper RD; Edvinsson L; Ekman R; Lambert GA
Cephalalgia; 1993 Jun; 13(3):180-3; discussion 149. PubMed ID: 8395344
[TBL] [Abstract][Full Text] [Related]
16. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
Buzzi MG; Moskowitz MA
Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
[TBL] [Abstract][Full Text] [Related]
17. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
18. No increase of calcitonin gene-related peptide in jugular blood during migraine.
Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
[TBL] [Abstract][Full Text] [Related]
19. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
20. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
Akerman S; Goadsby PJ
Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
